Seattle biotech firm Impel NeuroPharma files for $75M IPO

Impel CEO Adrian Adams. (Impel Photo) Seattle-based biotech company Impel NeuroPharma is set to go

Read the full article at contacted.org...

Found and curated by

SMB

Comments

Popular posts from this blog

How 20-Somethings Can Become Employable In 2021

Team Coaching Competencies 2 and 3